Rodney Arthur, MD
Nephrology · Harrisonburg, VANPI 1285699215
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 64.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $236 and has fallen 98.6% since, to $3 in 2025. That places this record below the midpoint for nephrology clinicians in VA, where the typical reported total is $807.
Across 18 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$189
- Johnson & Johnson$45
- Travere Therapeutics, Inc.$34
- Akebia Therapeutics Inc$25
What the payments were for
- Travel & lodging$7024%
- Food & beverage$16356%
- Education$5820%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 9 | $189 |
| Johnson & Johnson | 1 | $45 |
| Travere Therapeutics, Inc. | 7 | $34 |
| Akebia Therapeutics Inc | 1 | $25 |
How this compares
$292 in reported general payments places this provider in the 30th percentile of 298 nephrology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 206 | $248,633 |
| JardianceEmpagliflozin | 112 | $128,241 |
| OzempicSemaglutide | 60 | $67,378 |
| JanuviaSitagliptin Phosphate | 48 | $61,015 |
| EliquisApixaban | 41 | $57,989 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $15,769 |
| TrulicityDulaglutide | 16 | $13,221 |
| Sevelamer Carbonate | 44 | $8,171 |
| DapagliflozinDapagliflozin Propanediol | 13 | $7,757 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $6,726 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $3,765 |
| Losartan Potassium | 344 | $3,192 |
| Nifedipine ErNifedipine | 66 | $2,733 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 21 | $2,453 |
| Atorvastatin Calcium | 240 | $2,327 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Harrisonburg
- Ramon MendezWoodbridge$791K
- Reza ZonoziFairfax$262K
- Sandeep MagoonNorfolk$204K
- Thomas McCuneNorfolk$202K
- Gaurav GuptaRichmond$168K
- Csaba KovesdySalem$152K
- Ramin TolouianNorfolk$115K
- Mahesh KrishnanMc Lean$115K
- Mitchell RosnerCharlottesville$105K
- Neeraja TandraReston$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.